Use of clodronate for painful knee prosthesis in osteoarthritis patients: a 6-month pilot study.

Minerva Med

School of Medical and Pharmaceutical Sciences, Research Center of Osteoporosis and Osteoarticular Pathologies, University of Genoa, Genoa, Italy.

Published: December 2020

AI Article Synopsis

  • Knee replacement surgery often leads to pain from prosthetic devices, prompting the exploration of bisphosphonates like clodronate (CLO) for treatment due to their analgesic and anti-inflammatory benefits.
  • In a pilot study with 18 patients averaging 73 years old, participants received CLO alongside rehabilitation to assess changes in pain and functionality over 6 months, using pain and activity scores as metrics.
  • Results showed significant reductions in pain (VAS score decrease) and improvements in functionality (higher TLS score), suggesting that CLO combined with rehab exercises effectively alleviates pain and enhances the function of knee prostheses, with a high initial dose proving more beneficial than weekly doses.

Article Abstract

Background: Knee replacement surgery is one of the most common surgical procedures performed worldwide. Unfortunately, knee prostheses can become painful over time, necessitating appropriate analgesic treatment. Bisphosphonates such as clodronate (CLO) may play an important role in the treatment of painful knee prostheses by virtue of its analgesic and anti-inflammatory properties.

Methods: In this prospective open label pilot study, eighteen consecutive patients aged 73.2±8.9 years affected by knee painful prosthesis and osteoarthritis were treated with a rehabilitation cycle in addition to i.v. or i.m. CLO. Induction dose was 2.0-2.1g, followed by a weekly dose of 200 mg (i.m.) for 6 months. Visual analogue scale (VAS) pain score and Tegner Lysholm Score (TLS) were used to assess improvement following CLO treatment.

Results: Thirteen out of 18 patients completed the 6-month follow-up. VAS pain score decreased from 8.1±1.8 at baseline to 5.6±2.6 (P<0.05) and TLS increased from 40.4±20.3 at baseline to 62.7±24.1 at 6 months (P<0.05). Univariate regression revealed that among a range of variables, BMI was positively correlated with VAS (r=0.73, P=0.004) and lower TLS after 1 month (r= -0.62, P=0.006).

Conclusions: CLO in association with rehabilitation exercises can reduce pain and ameliorate the functionality of painful knee prostheses. Administration of a high dose (induction dose) of CLO every 3 months appears to be the most effective regimen compared to a weekly maintenance dose.

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0026-4806.20.06706-3DOI Listing

Publication Analysis

Top Keywords

painful knee
8
prosthesis osteoarthritis
8
pilot study
8
knee prostheses
8
vas pain
8
pain score
8
knee
5
clodronate painful
4
knee prosthesis
4
osteoarthritis patients
4

Similar Publications

Background: Although total hip and total knee arthroplasty are highly successful operations, the decision of whether and when to undergo surgery is highly subjective and discretionary, and specific guidelines regarding readiness for surgery remain elusive. The nature of these decisions underscores the importance of shared decision-making, which is founded on the concept that patients substantially contribute to determining their own readiness for surgery. The OPTION survey was developed as a conversation aid to facilitate shared decision-making in the context of total joint arthroplasty.

View Article and Find Full Text PDF

Background: Knee injuries are common among elite intercounty Gaelic games players (collectively GAA players).

Aims: The primary aim was to examine knee pain, function, and quality of life in retired elite male GAA players. Secondary objectives were to (i) report the incidence of previous knee surgery and total knee replacement, (ii) assess medication usage, and (iii) investigate any associations between a history of knee injury and/or knee surgery and knee pain, function, and quality of life among retired elite male GAA players.

View Article and Find Full Text PDF

Range of Flexion Improvement in Degenerative Stages of the First Metatarsophalangeal Joint () with Cross-Linked Hyaluronic Acid: A Cadaveric Study.

J Funct Morphol Kinesiol

December 2024

Human Anatomy and Embryology Unit, Experimental Pathology and Therapeutics Department, Faculty of Medicine and Health Sciences, University of Barcelona, 08907 Hospitalet, Spain.

Background: Viscosupplementation consists of intraarticular hyaluronic acid injections applied to treat pain and improve joint mobility. The objective of the study was to analyze the improvement of the range of mobility of the first metatarsophalangeal joint with a single dose of cross-linked hyaluronic acid.

Methods: Ten fresh frozen specimens of feet sectioned below the knee were selected.

View Article and Find Full Text PDF

: Pain is the most common symptom of osteoarthritis (OA), and it leads to functional decline, such as decreased mobility and limitations in activities of daily living, which leads to difficulties in social participation, increased social isolation, and economic burden. Muscle weakness can be a cause of OA symptoms. The purpose was to analyze the effects of resistance training on improving pain, strength, and function in OA and to analyze the effects by intervention duration and joint.

View Article and Find Full Text PDF

Native knee joint infections, while uncommon, present a serious condition predominantly instigated by bacteria such as . Without timely intervention, they can result in joint destruction or sepsis, with risk factors encompassing preexisting medical conditions and iatrogenic procedures. The diagnostic process includes a comprehensive patient history, clinical evaluation, laboratory testing, imaging studies, and microbiological investigations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!